Validation and use of the Children's Hope Scale-revised PTPB edition (CHS-PTPB): high initial youth hope and elevated baseline symptomatology predict poor treatment outcomes.

The present study examined the relationship between initial youth hope, measured within the first 4 weeks of mental health treatment, and treatment progress over time (self-, caregiver-, and clinician-report of symptom severity) in a clinical sample of youth ages 11-18 years (N = 356). The psychometric properties of the CHS-PTPB, a revised version of the Children's Hope Scale, are also presented. Results indicate the CHS-PTPB is a psychometrically sound measure for use in this population.

Validation and use of the youth and caregiver Treatment Outcome Expectations Scale (TOES) to assess the relationships between expectations, pretreatment characteristics, and outcomes.

This study introduces the youth and caregiver versions of the Treatment Outcome Expectations Scale (TOES) and presents the results of comprehensive psychometric analyses in a large sample of clinically-referred youth (N = 291) ages 11-18 and their caregivers (N = 268). This study also examines whether expectations are predictive of early or overall treatment change as measured by changes in youth symptom severity rated by multiple respondents (youth, caregiver, and clinician). Additionally, the relationship between treatment outcome expectations and several background, pretreatment, and clinical variables is explored.

Brief Multidimensional Students' Life Satisfaction Scale-PTPB Version (BMSLSS-PTPB): psychometric properties and relationship with mental health symptom severity over time.

Youth life satisfaction is a component of subjective well-being, an important part of a strengths-based approach to treatment. This study establishes the psychometric properties of the Brief Multidimensional Students' Life Satisfaction Scale-PTPB Version (BMSLSS-PTPB). The BMSLSS-PTPB showed evidence of construct validity with significant correlations as expected to measures of youth hope and youth symptom severity, and no relationship as expected to youth treatment outcome expectations.